 acid treatment elderli patient acut myeloid leukemia phase II pilot studi eastern cooper oncolog group manag acut myeloid leukemia elderli year unsatisfactori poor patient toler standard myeloabl chemotherapi author phase II studi effect toxic acid cra therapi elderli patient acut myeloid leukemia aml patient leukocyt count cra leukocyt count hydroxyurea cra twelv patient week cra evalu toxic respons object respons cis-retino acid administr modest dermatolog musculoskelet gastrointestin toxic altern therapeut strategi subpopul aml patient